Full-Time

New Business Operations and Enablement Lead Director

Trade Strategy & Innovation

Posted on 5/9/2026

Deadline 6/7/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$100k - $231.5k/yr

+ Bonus + Commission + Short-term Incentive + Equity Award

Company Historically Provides H1B Sponsorship

Illinois, USA

Remote

Category
Business & Strategy (1)
Requirements
  • 8+ years’ experience, ideally with a strong understanding of pharmaceutical manufacturer market access models and patient education and engagement solutions
  • Experience building, scaling, or supporting sales operations and enablement, including onboarding, training, marketing collateral content, and continuous learning initiatives
  • Bachelor’s degree in Healthcare, Business, Finance, Economics, Operations, or related fields
  • The candidate will be expected to have the following key attributes: strong work ethic, self-starter, productive in dynamic, collaborative environment
Responsibilities
  • Manage financial obligations associated with enhanced services agreements with pharmaceutical manufacturer partners, ensuring alignment with contractual terms and internal governance requirements
  • Monitor and track enhanced services milestones that trigger invoicing, reporting deliverables, and other contractual commitments
  • Own the end‑to‑end enhanced services invoicing process, ensuring billing accuracy, compliance with contract terms, and timely receipt of payment
  • Partner closely with New Business Development to track and report partnership opportunity pipeline, contract status, and associated revenue
  • Represent the New Business Development organization in the development of enhanced services marketing and sales materials, ensuring clear communication of the solution’s value-proposition
  • Coordinate industry conference and tradeshow activities, including development of presentation materials, meeting agendas, leadership preparation, scheduling, and related logistical support
  • Identify and implement process improvement and reporting enhancements that reduce administrative burden and increase operational efficiency for the New Business Development team
  • Track New Business Development contracting progress and proactively coordinate with internal stakeholders to streamline feedback cycles and accelerate time to contract execution
Desired Qualifications
  • Proven self‑starter with a continuous improvement orientation and a bias toward operational efficiency and automation
  • Results‑oriented professional with a track record of improving deal velocity, execution quality, and operational accuracy
  • Demonstrated experience supporting change management, process optimization, or system implementations
  • Advanced proficiency in Excel, including complex formulas, models, and dashboard development; experience with business intelligence tools (e.g., Tableau, Power BI) preferred
  • Comfortable operating amid ambiguity and evolving business priorities, with the agility to adapt as needs change
  • Demonstrated customer‑centric mindset with a strong understanding of sales and business development team needs
  • Highly collaborative, with the ability to align and partner effectively across New Business Development, Product Development, Legal, Finance, and Analytics teams
  • Ability to manage multiple, concurrent initiatives while meeting deadlines and maintaining high quality standards
  • Exceptional attention to detail while maintaining a clear understanding of broader commercial and organizational objectives
  • Strong analytical and data‑driven mindset, with the ability to translate insights into actionable outcomes

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue exceeded $100B, up 6% year-over-year.
  • Medical benefit ratio improved to 84.6%, signaling better cost management.
  • Pharmacy-only locations in underserved areas drive medication access expansion.

What critics are saying

  • Amazon Pharmacy captures 20% urban market share with next-day delivery.
  • FTC settlement forces PBM margin cuts of 15-20% through transparency.
  • State-level spread pricing bans eliminate $2-3B annual pharmacy revenue.

What makes CVS Health unique

  • Integrated model combines insurance, pharmacy, and primary care clinics uniquely.
  • Over 800 MinuteClinic locations and 24/7 virtual care nationwide.
  • Aetna serves 26 million medical members with broad health plans.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at CVS Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

PR Newswire
Mar 30th, 2026
CVS opens first pharmacy-only location in Chicago, plans nearly 20 this year

CVS Health has opened its first pharmacy-only location in Chicago, part of plans to launch nearly 20 such sites across the US this year. The 3,000-square-foot store at 2628 West Pershing Road features a full-service pharmacy with selected over-the-counter products. The pharmacy-only format is designed to increase access to medications, immunizations and pharmacist consultations in underserved communities. Additional locations are planned for Houston, Roxbury, Detroit and Brooklyn in 2026, alongside more than 40 traditional CVS Pharmacy stores. The move responds to consumer preferences, with CVS's 2025 research showing 80% of patients prefer face-to-face pharmacy care and 48% would switch pharmacies if limited to digital-only options. The company opened its first pharmacy-only site in Birmingham, Alabama, late last year.

Yahoo Finance
Mar 26th, 2026
CVS settles FTC insulin pricing probe as regulatory scrutiny of pharmacy benefit manager intensifies

CVS Health has reached a proposed settlement with the Federal Trade Commission over insulin pricing practices at its Caremark pharmacy benefit manager unit. The company also declared a quarterly dividend of $0.665 per share, payable on 4 May 2026. The settlement places CVS's pharmacy benefit management model under increased regulatory scrutiny regarding drug cost transparency. The company's investment narrative centres on its integrated model across insurance, pharmacy and care delivery, with near-term focus on restoring profitability in healthcare delivery and PBM services. CVS recently appointed former Elevance Health CFO John E. Gallina to its board as an audit committee financial expert. The company's narrative projects $445.5 billion revenue and $10.2 billion earnings by 2029, implying a fair value of $96.50 per share.

Yahoo Finance
Mar 23rd, 2026
Bernstein upgrades CVS Health to Outperform with $94 price target amid Medicare Advantage turnaround

Bernstein analyst Lance Wilkes upgraded CVS Health to "Outperform" from "Market Perform" on 12 March, raising the price target to $94 from $91. The upgrade reflects the company's attractive exposure to the Medicare Advantage turnaround and expectations of stable earnings in its pharmacy and pharmacy benefit manager businesses following reforms. Wilkes cited the PBM bill passage and the Federal Trade Commission settlement with Cigna as clearing events for the stock. Separately, CVS Health announced a strategic partnership with Google Cloud focused on reimagining healthcare experiences through its new health technology subsidiary, Health100, which will offer AI-powered healthcare services. CVS Health operates as a diversified healthcare company combining insurance, pharmacy benefit management, retail pharmacies and clinical services across the United States.

Yahoo Finance
Mar 13th, 2026
CVS Health's Aetna unit pays $117.7M to settle Medicare Advantage fraud allegations

Aetna, a CVS Health subsidiary, has agreed to pay $117.7 million to the US Department of Justice to settle allegations that it submitted inaccurate diagnosis codes for Medicare Advantage members to increase reimbursements. The settlement resolves longstanding False Claims Act allegations related to the Medicare Advantage programme. CVS Health shares recently closed at $76.07, down 5.1% year-to-date, though up 20.1% over the past year. The settlement is material for the company, which has thin net margins of 0.4% and debt not well covered by operating cash flow. The agreement highlights compliance risks in CVS Health's government-facing insurance operations, a central part of its Medicare Advantage business. Analysts' average target price stands at $96.50, approximately 27% above current levels.

Yahoo Finance
Mar 7th, 2026
Alphabet faces wrongful death lawsuit over Gemini AI chatbot while expanding healthcare partnership with CVS

Alphabet faces a wrongful death lawsuit alleging its Gemini AI chatbot contributed to a user's suicide, reportedly the first legal case directly linking Google's AI tools to a death. Simultaneously, the company announced a healthcare AI partnership with CVS Health focused on a real-time consumer engagement platform. The contrasting developments underscore Alphabet's expanding role in high-stakes sectors. The CVS collaboration integrates Gemini into Health100, a platform handling personal interactions across insurers, pharmacies and care providers. Meanwhile, the lawsuit tests whether conversational AI design and crisis protocols carry a duty of care, even outside formal healthcare settings. For investors, the key questions centre on how Alphabet manages legal risk, establishes guardrails and navigates regulatory oversight as its AI tools penetrate sectors requiring heightened safety and compliance standards.